Bioequivalence and Bioavailability Forum

ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by Helmut  – Vienna, Austria, 2020-02-12 14:12 (1527 d 12:46 ago) – Posting: # 21164
Views: 6,331

Hi ElMaestro,

❝ ❝ ignorance of the intra-individual variability of the drug;

❝

❝

❝ Ermmm...... WHAT????

Lost in translation?

É aceitável usar uma abordagem de dois estágios para demonstrar a bioequivalência baseada nodesconhecimento da variabilidade do fármaco;

I have the same translation like Mauricio. Google-translate suggests ‘unknowing’ for ‘nodesconhecimento’ but if you feed the entire sentence, ‘ignorance’ shows up.

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! 
Helmut Schütz


The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

• ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-11 20:52 [Two-Stage / GS Designs] 
  • Brainless copy-and-paste-devil Helmut 2020-02-12 02:26
    • Brainless copy-and-paste-devil Mauricio Sampaio 2020-02-12 17:33
  • ANVISA guidelines for two-stage design ElMaestro 2020-02-12 08:27
    • ANVISA guidelines for two-stage design nobody 2020-02-12 08:49
    • ANVISA guidelines for two-stage designHelmut 2020-02-12 13:12
    • ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-12 17:04
    • ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-12 17:11
  • ANVISA guidelines for two-stage design ElMaestro 2020-02-12 21:54
    • crap Helmut 2020-02-15 17:53
      • crap Mauricio Sampaio 2020-02-16 05:01
        • crap Helmut 2020-02-16 15:43
          • crap d_labes 2020-02-16 19:34
            • Explained crap remains crap Helmut 2020-02-17 12:49
              • Proposed changes Mauricio Sampaio 2020-02-17 13:50
                • Proposed changes Helmut 2020-02-17 14:16